跳至主要内容
临床试验/NCT01886586
NCT01886586已完成不适用

RECALL: Retaining Cognition While Avoiding Late-Life Depression

University of Pittsburgh2 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2011年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
94
试验地点
2
主要终点
Incidence of depression or anxiety disorders

研究概览

简要总结

This study will adapt Problem Solving Therapy (PST) for individuals with mild cognitive impairment (MCI) as an intervention for preventing major depression (DEP). PST will be modified so as to be provided to both MCI probands as well as their support person. The primary aim is to examine the effectiveness of PST in individuals with MCI and the support person, at preventing DEP over 12 mos. in MCI probands. We also will examine the effect of exercise on preventing depression.

详细描述

The Recall Study (Retaining Cognition while Avoiding Late-Life Depression) is a study for adults 60 and older who have noticed mild memory changes in themselves or a loved one. Mild memory changes may feel stressful and therefore increase an individual's risk of developing depression. This research project will test whether Problem Solving Therapy (PST) is successful in preventing major depression for those living with mild cognitive impairments. We will also examine the effect of modest exercise on mood. You will participate in 8 to 12 PST sessions over 16 weeks. All treatments are provided at no cost and there is compensation for participation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •MCI participant Inclusion Criteria:
  • •Modified Mini Mental State (3MS) => 80
  • •MCI diagnosis
  • •Adequate physical and sensory function to undergo NP assessment
  • •PHQ-9 score 1-9, with at least one of the cardinal symptoms of depression (low mood or anhedonia) endorsed.
  • •MCI participant

排除标准

  • •Major Depressive Episode or anxiety disorder within the past 1 year
  • •Currently taking an anti-depressant
  • •History of Bipolar Disorder or Schizophrenia
  • •Drug or alcohol use disorder within 12 months
  • •Currently taking anti-anxiety med >4x/week for the past 4 weeks
  • •Support person Inclusion Criteria:
  • •Modified Mini Mental State (3MS) => 80
  • •Normal Cognitive Function
  • •Adequate physical and sensory function to undergo NP assessment
  • •PHQ-9 score 1-9, with at least one of the cardinal symptoms of depression (low mood or anhedonia) endorsed.
  • •Support person Exclusion Criteria:
  • •Major Depressive Episode or anxiety disorder within the past 1 year
  • •Currently taking an anti-depressant
  • •History of Bipolar Disorder or Schizophrenia
  • •Drug or alcohol use disorder within 12 months
  • •Currently taking anti-anxiety med >4x/week for the past 4 weeks

研究组 & 干预措施

Problem Solving Therapy

Active Comparator

8-12 sessions of Problem Solving Therapy (both members of dyad)

干预措施: Problem Solving Therapy (Behavioral)

Problem Solving Therapy + Exercise

Active Comparator

6-12 sessions of Problem Solving Therapy + Exercise (both members of dyad)

干预措施: Problem Solving Therapy + Exercise (Behavioral)

Enhanced Usual Care

Active Comparator

Staff will will document and monitor all mental health treatment (e.g., medications that participant may be taking) and psychotherapy (e.g. counseling or social services).

干预措施: Enhanced Usual Care (Other)

结局指标

主要结局

Incidence of depression or anxiety disorders

时间窗: 15 months

PHQ9, prime-MD SCID, GAD7

次要结局

  • Change in cognitive function measured by RBANS and DKEFS(15 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Meryl Butters

Associate Professor

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验